John Hussman's MEDP Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 6,300 shares of Medpace Holdings, Inc. (MEDP) worth $3.03 M, representing 0.65% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, John Hussman has maintained this position in MEDP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 6,300 shares. Largest reduction occurred in Q4 2023, reducing 4,200 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,300 | New Buy | 6,300 | $480.19 |
| Q4 2024 | -4,200 | Sold Out | 0 | $0.00 |
| Q3 2024 | +4,200 | New Buy | 4,200 | $333.80 |
| Q4 2023 | -4,200 | Sold Out | 0 | $0.00 |
| Q3 2023 | +4,200 | New Buy | 4,200 | $242.13 |
John Hussman's Medpace Holdings Investment FAQs
John Hussman first purchased Medpace Holdings, Inc. (MEDP) in Q3 2023, acquiring 4,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Medpace Holdings, Inc. (MEDP) for 5 quarters since Q3 2023.
John Hussman's largest addition to Medpace Holdings, Inc. (MEDP) was in Q1 2026, adding 6,300 shares worth $3.03 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 6,300 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $3.03 M.
As of the Q1 2026 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.65% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Medpace Holdings, Inc. (MEDP) was 6,300 shares, as reported at the end of Q1 2026.